HealthStream (HSTM) Q2 2026 earnings review
Record Top-Line Growth Masking Softer Net Income Outlook
HealthStream delivered a record $83.7M in Q2 revenue, accelerating to 12.5% YoY growth. However, this top-line surge was flattered by a $2.0M one-time variable consideration catch-up and $3.1M from recent acquisitions. Excluding these, organic revenue growth was a more modest, yet stable, 5.6%. Adjusted EBITDA grew a healthy 16.9% to $20.6M. While management confidently raised FY26 revenue and EBITDA guidance, they quietly lowered Net Income expectations by roughly $0.75M at the midpoint, signaling higher depreciation and amortization costs from their aggressive investment and M&A strategy.
🐂 Bull Case
Revenue growth has accelerated for five consecutive quarters, breaking out of the mid-single-digit range to 12.5%. The core platform is successfully absorbing and monetizing new users.
Operating income surged 41.4% to $8.3M, driven by higher revenues and favorable sublease income. The company is extracting better margins from its existing footprint.
🐻 Bear Case
Despite raising EBITDA, FY26 net income guidance was lowered to $19.5-22.2M (from $20.4-22.8M). This suggests heavy below-the-line costs, specifically rising D&A from capitalized software and M&A.
The $83.7M revenue figure includes a $2.0M one-time accounting catch-up. Without it, the quarter's growth rate was closer to 9.8%—still strong, but less explosive than the headline suggests.
⚖️ Verdict: ⚪
Neutral to Bullish. The operational execution is solid, and the top-line acceleration is genuine, even when stripping out the one-time catch-up. However, the diverging guidance (EBITDA up, Net Income down) warrants caution regarding the true cash-conversion quality of recent investments.
Key Themes
M&A Strategy Delivering Expected Growth
The Q4 2025 acquisitions of Virsys12 and MissionCare Collective are executing as planned, contributing $3.1M to Q2 revenue. This paces well against management's prior guidance of roughly ~$13M in full-year contribution, cementing HealthStream's expansion into payer credentialing and direct caregiver networks.
Net Income Guidance Diverges from EBITDA
A specific contradiction emerged in the guidance update: management raised FY26 Adjusted EBITDA by $1M at the midpoint, yet lowered Net Income by $0.75M. With projected FY26 D&A at $45.3-$45.7M (nearly double the Net Income), the aggressive capitalization of software development and M&A intangibles is creating a structural headwind to bottom-line GAAP profitability.
Quality of the Earnings Beat
Q2 revenue accelerated to 12.5%, but the underlying quality is slightly muddy. A $2.0M resolution of constrained variable consideration (cumulative ASC 606 catch-up) accounted for nearly 25% of the total year-over-year revenue dollar increase ($9.3M). Investors should base forward models on the normalized ~9.8% growth rate.
Macro Tailwinds in Healthcare Labor
The company continues to benefit from secular macro trends. With the Bureau of Labor Statistics projecting healthcare to account for a quarter of all new U.S. jobs, HealthStream's core TAM is expanding organically, insulating it from the seat-compression risks that threaten other enterprise SaaS models in the AI era.
Platform Interoperability & AI Expansion
HealthStream is continuously driving its ecosystem strategy by moving customers to the hStream platform and introducing new native applications like the HealthStream Learning Experience (HLX). The ongoing capitalization of software ($14.2M in H1 2026) indicates heavy reinvestment into AI capabilities and platform interoperability, directly trading short-term margin expansion for long-term stickiness.
Persistent Legacy Product Drag
While not explicitly quantified in the Q2 release, historical commentary indicates the sunsetting of legacy scheduling and credentialing platforms (like ANSOS) continues to offset the hyper-growth of modern SaaS suites like CredentialStream and ShiftWizard. This transition requires ongoing monitoring until the legacy base is immaterial.
Other KPIs
Accelerating significantly, up 41.4% YoY. This was driven by a combination of higher subscription revenues and ongoing income from an office sublease initiated in Q2 2025. It demonstrates strong operating leverage despite higher investments in personnel, third-party software, and cloud hosting.
Up sharply from $32.1M in H1 2025. This strong cash generation fully funded $14.2M in capitalized software development and $8.6M in capital returns (dividends and buybacks), allowing cash balances to grow to $46.2M while maintaining a debt-free balance sheet.
Guidance
Accelerating. Raised from the prior $323.0-$330.0M range. The new midpoint ($329.5M) implies an 8.4% YoY growth rate over FY25's $304.1M, confirming momentum in both the core platform and recently acquired segments.
Accelerating. Raised from the prior $73.0-$77.0M range. The midpoint implies 5.9% YoY growth from FY25. However, this growth rate is noticeably slower than the 16.9% posted in Q2, indicating management's intent to aggressively reinvest Q1/Q2 outperformance into H2 sales and technology initiatives.
Reversing. Lowered from the prior $20.4-$22.8M estimate. The midpoint ($20.85M) suggests a potential year-over-year contraction compared to FY25's adjusted net income. Management projects heavy depreciation and amortization ($45.3-$45.7M) acting as an anchor.
Key Questions
Bridge the Net Income and EBITDA Divergence
You raised FY26 EBITDA guidance but lowered Net Income guidance. Can you precisely bridge this gap? How much of the rising D&A is driven by the recent acquisitions versus capitalized software for the core hStream platform?
Normalized Organic Growth Trajectory
Excluding the $2.0 million cumulative catch-up and the $3.1 million from M&A, your core revenue grew around 5.6%. Is this a normalized run-rate we should expect for the core organic business in the second half of the year?
Update on Legacy Headwinds
In previous quarters, legacy product sunsetting was a material drag on top-line growth. Has the legacy revenue base now shrunk to a level where it is no longer a significant headwind to overall consolidated growth?